This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Richards, S. Articles by Iannaccone, S. T. Search for Related Content PubMed PubMed Citation Articles by Richards, S. Articles by Iannaccone, S. T. Social Bookmarking                         What's this?

Dystrophin and DNA Diagnosis in a Large Pediatric Muscle Clinic

GeneScreen, Department of Pediatrics

Susan T. Iannaccone, MD

Texas Scottish Rite Hospital, Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

Eighty-seven unrelated patients from a large muscle clinic setting were analyzed by DNA for deletions in the dystrophin gene for diagnosis of Duchenne/Becker muscular dystrophy. The clinical phenotype of the patient population included 72% Duchenne, 13% Becker, and 15% outlier patients. Dystrophin gene deletions were detected in 61% of these patients, and disease phenotype was predicted by DNA with an accuracy of 95%. While DNA did not confirm diagnosis in all patients, dystrophin analysis of muscle biopsies, when available, predicted a disease phenotype. In the 66 patients in which muscle biopsies were available for analysis, the results of the dystrophin analysis agreed with actual clinical phenotype with 86% accuracy. Less agreement between dystrophin and clinical phenotype predictions were found in the Becker patient population. We suggest that, in at least 61% of Duchenne/Becker patients, DNA analysis provides a rapid and accurate diagnosis. DNA is less invasive and less expensive than biopsy and may allow family risk assessment. Therefore, DNA analysis may become the first recommended laboratory procedure for Duchenne/Becker diagnosis, and muscle biopsy with dystrophin analysis may become necessary only for those patients with undetectable gene mutations. (J Child Neurol 1994;9:162-166).

Journal of Child Neurology, Vol. 9, No. 2, 162-166 (1994)
DOI: 10.1177/088307389400900211


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. J. Samaha and J. G. Quinlan Topical Review: Dystrophinopathies: Clarification and Complication J Child Neurol, January 1, 1996; 11(1): 13 - 20. [Abstract] [PDF]